Pharmacoepigenomic profile of ovarian cancer patients submitted to taxane-based chemoteherapy

Dados básicos

Código:
Estudo Clínico Académico
Protocolo:
Estudo Clínico Académico
EUDRACT:
NCT:
Centro:
Dotação:
Ano de início:
2020
Ano de conclusão:
Estudos observacionais Nacional Não Financiado Outros

Objectivos do projeto

Estudos Observacionais (STROBE statement); Natureza do Promotor: Academia – Tipo não comercial – Iniciativa do Investigador; Tipo de Centro: Unicêntrico – Cuidados Secundários

Documentos

  • Não há documentos

Participantes

Stakeholders - Promotores

FMUP

Outputs do ensaio clínico


A hint for the obesity paradox and the link between obesity, perirenal adipose tissue and Renal Cell Carcinoma progression

Preza-Fernandes, J; (...); Ribeiro, R

Article. 10.1038/s41598-022-24418-9. 2022

  • Open Access.

A quick and low-intensity method for oral administration to large numbers of mice: A possible alternative to oral gavage

Neto, T; (...); Oliveira, PA

Article. 10.1177/00236772211035250. 2022


ASCT2 and LAT1 Contribution to the Hallmarks of Cancer: From a Molecular Perspective to Clinical Translation

Lopes, C, Pereira, A., Medeiros, R.

Article. 10.3390/cancers13020203. 2021


ceRNA Network of lncRNA/miRNA as Circulating Prognostic Biomarkers in Non-Hodgkin Lymphomas: Bioinformatic Analysis and Assessment of Their Prognostic Value in an NHL Cohort

Fernandes, M; (...); Medeiros, R

Article. 10.3390/ijms23010201. 2022

  • Open Access.

ceRNA Network of lncRNA/miRNA as Circulating Prognostic Biomarkers in Non-Hodgkin Lymphomas: Bioinformatic Analysis and Assessment of Their Prognostic Value in an NHL Cohort.

Fernandes, M; (...); Medeiros, R

Article. 2022


Circulating lncRNA- and miRNA-Associated ceRNA Network as a Potential Prognostic Biomarker for Non-Hodgkin Lymphoma: A Bioinformatics Analysis and a Pilot Study

Fernandes, M; (...); Medeiros, R

Article. 10.3390/biomedicines10061322. 2022

  • Open Access.

Circulating lncRNA- and miRNA-Associated ceRNA Network as a Potential Prognostic Biomarker for Non-Hodgkin Lymphoma: A Bioinformatics Analysis and a Pilot Study.

Fernandes, M; (...); Medeiros, R

Article. 2022


Comment on DKK1 inhibits canonical Wnt signaling in human papillomavirus-positive penile cancer cells

Brito, HO; (...); da Costa, RMG

Editorial Material. 10.1016/j.tranon.2021.101326. 2022

  • Open Access.

Competitive Endogenous RNA Network Involving miRNA and lncRNA in Non-Hodgkin Lymphoma: Current Advances and Clinical Perspectives

Oliveira Fernandes, M.; (...); Medeiros, R.

Article. 10.3390/biomedicines9121934. 2021

  • Open Access.

Competitive Endogenous RNA Network Involving miRNA and lncRNA in Non-Hodgkin Lymphoma: Current Advances and Clinical Perspectives.

Fernandes, M; (...); Medeiros, R

Article. 2021


Differential Incidence of Tongue Base Cancer in Male and Female HPV16-Transgenic Mice: Role of Female Sex Hormone Receptors

Neto, CPD; (...); Brito, LMO

Article. 10.3390/pathogens10101224. 2021

  • Open Access.

Extracellular Vesicles Derived-LAT1 mRNA as a Powerful Inducer of Colorectal Cancer Aggressive Phenotype

Almeida, C; (...); Medeiros, R

Article. 10.3390/biology11010145. 2022

  • Open Access.

Long Non-Coding RNAs in Venous Thromboembolism: Where Do We Stand?

Marques, IS; (...); Medeiros, R

Review. 10.3390/ijms241512103. 2023

  • Open Access.

miRNA- and lncRNA-Based Therapeutics for Non-Hodgkin's Lymphoma: Moving towards an RNA-Guided Precision Medicine

Fernandes, M; (...); Medeiros, R

Review. 10.3390/cancers13246324. 2021

  • Open Access.

miRNA- and lncRNA-Based Therapeutics for Non-Hodgkin's Lymphoma: Moving towards an RNA-Guided Precision Medicine.

Fernandes, M; (...); Medeiros, R

Article. 2021


Risk factors among stroke subtypes and its impact on the clinical outcome of patients of Northern Portugal under previous aspirin therapy.

Freitas Silva, M, Medeiros, R, Nunes, JPL

Article. 2021


Venous thromboembolism-related genetic determinant F11 rs4253417 is a potential prognostic factor in ischaemic stroke

Tavares, Valeria; (...); Medeiros, Rui

Article. 10.1016/j.mcp.2023.101917. 2023

  • Open Access.

Identificação De Determinantes Farmacogenómicas Preditivas De Resposta Ao Tratamento Em Doentes Com Cancro Do Colo Do Útero

Tese de doutoramento

Colaboradores: Rui Manuel de Medeiros Melo Silva


Identification Of Dysregulated Long Non-Coding Rnas In Hpv-Induced Carcinogenesis And Cancer Cachexia

Dissertação de Mestrado

Colaboradores: Rui Manuel de Medeiros Melo Silva


Microenvirinment Influence In Non-Hodgkin Lymphoma Chemotherapy Response

Tese de doutoramento

Colaboradores: Rui Manuel de Medeiros Melo Silva


The Role Of Micrornas And Mast Cells Infiltration In Hpv-Induced Carcinogenesis: Studies In K14-Hpv16 Transgenic Mice

Dissertação de Mestrado

Colaboradores: Rui Manuel de Medeiros Melo Silva


Partilhar